Niemann Pick type C - PIAM farmaceutici s.p.a
Por um escritor misterioso
Descrição
Niemann Pick type C is a disease of lysosomal lipid accumulation: patients with this disease are unable to metabolise lipids (e.g. cholesterol) properly, and they tend to accumulate lipids in the liver, spleen and other organs. The prevalence in the general population is about 1/100,000. The disease is characterized by autosomal recessive transmission and can […]
PIAM farmaceutici Pharma & Integrative care
Niemann-Pick type C: contemporary diagnosis and treatment of a classical disorder
Type 1 Tyrosinemia (HT-1) - PIAM farmaceutici s.p.a
5 Most Promising Companies offering hope to patients with Niemann-Pick Type C
Potential treatment for Niemann-Pick type C, a rare neurodegenerative disease
Niemann–Pick Disease Type C
Niemann-Pick Disease Type C Treatment Market Size & Trends 2020- expected to reach US$ 378.8 Million With CAGR of 42.3% by 2027, Orphazyme A/S, Cyclo Therapeutics, Inc., and Johnson & Johnson
Niemann Pick Disease Type C - Symptoms, Causes, Treatment
Niemann Pick Disease - an overview
Niemann Pick C - Dipharma SA
Niemann–Pick disease - Wikipedia
New Drug Application for Niemann-Pick Disease Type C Treatment - Patient Worthy
5 Most Promising Companies offering hope to patients with Niemann-Pick Type C
Niemann–Pick type C disease: cellular pathology and pharmacotherapy - Wheeler - 2020 - Journal of Neurochemistry - Wiley Online Library
Niemann-Pick disease type C: Video & Anatomy